DeepChain
Industry-leading biology AI solutions for a healthier, more sustainable, and resilient world.
Charting new paths to superior medicines with cutting-edge AI-driven drug discovery.

Iambic Therapeutics is a cutting-edge biotechnology company leveraging a sophisticated AI-driven platform to solve the most challenging design problems in drug discovery. By seamlessly integrating accurate, data-efficient physics-based AI technologies with highly automated, high-throughput experimentation, Iambic accelerates the transition from novel molecular designs to actionable biological data on a weekly basis. This closed-loop system allows expert drug hunters to deeply explore chemical spaces, uncover novel mechanisms of action (such as cryptic pockets and allostery), and optimize target product profiles in parallel. The platform is proven to deliver highly differentiated, best-in-class clinical candidates years faster than the industry standard. Iambic’s pipeline currently includes highly selective, brain-penetrant HER2 inhibitors and CDK2/4 therapies designed to bypass dose-limiting toxicities. Additionally, through pioneering multi-modal transformer models like 'Enchant,' Iambic is successfully breaking down the data wall between preclinical and clinical R&D, positioning itself as a transformative partner for major pharmaceutical companies, evidenced by strategic collaborations with partners like Takeda.
Iambic Therapeutics is a cutting-edge biotechnology company leveraging a sophisticated AI-driven platform to solve the most challenging design problems in drug discovery.
Explore all tools that specialize in predictive modeling of molecular interactions. This domain focus ensures Iambic Therapeutics delivers optimized results for this specific requirement.
Explore all tools that specialize in parallel optimization of target product profiles. This domain focus ensures Iambic Therapeutics delivers optimized results for this specific requirement.
Explore all tools that specialize in preclinical and clinical data integration. This domain focus ensures Iambic Therapeutics delivers optimized results for this specific requirement.
Integrates core physics principles with machine learning to highly accurately model molecular interactions and binding affinities without massive empirical datasets.
Robotics and automated assay integration that seamlessly tests AI-generated molecular designs in physical biological assays.
A proprietary transformer neural network designed to ingest and correlate multi-modal datasets from both preclinical and clinical stages.
Advanced structural modeling to identify transient binding sites on proteins that are not visible in static crystal structures.
Simultaneous optimization of multiple molecular properties (efficacy, toxicity, pharmacokinetics) using multi-objective generative models.
Define unmet patient need and target product profiles
Deploy physics-based AI algorithms to explore chemical spaces
Generate novel molecular structures targeting designated pockets
Automate compound synthesis and high-throughput biological screening
Analyze weekly biological insights to refine generative AI models
All Set
Ready to go
Verified feedback from other users.
"Highly regarded by investors and enterprise partners for breaking biopharma R&D bottlenecks with actionable, clinical-stage outputs."
0Post questions, share tips, and help other users.
Industry-leading biology AI solutions for a healthier, more sustainable, and resilient world.